Emcure Pharmaceuticals Ltd. IPO

Emcure Pharmaceuticals Ltd.

IPO Listing Details

Listed On


Listed On

Issue Price


Issue Price

Listing Price


Listing Price

Listing Gains

+₹317.05 (+31.45%)

Listing Gains

IPO Details

Bidding Dates

03 Jul - 05 Jul '24

Bidding Dates

Min. Investment


Min. Investment

Lot Size


Lot Size

Price Range

₹960 - ₹1008

Price Range

Issue Size

1,316 Cr

Issue Size

Subscription Rate

  • Retail Individual Investor
  • Non-Institutional Investor
  • Qualified Institutional Buyers
  • Employees

About Company

Emcure Pharmaceuticals Limited, a prominent entity in India's pharmaceutical landscape, is celebrated for its expansive research, development, and global distribution of a diverse range of pharmaceutical products. The company's extensive portfolio includes oral medications, injectables, and biotherapeutics, serving over 70 countries with a significant presence in India, Europe, and Canada. Known for its stronghold in critical therapeutic areas like gynecology, HIV antivirals, and cardiovascular drugs, Emcure has established itself as a leader in the industry.

Important Dates - Emcure Pharmaceuticals IPO Limited IPO

Application opens on 03rd July 2024
Last date of application 05th July 2024
Date of Allotment 08th July 2024
Refund begins from 09th July 2024
Credit of shares to Demat 09th July 2024
Listing date 10th July 2024

Emcure Pharmaceuticals IPO Grey Market Premium

Date GMP
01st July Rs.267
30th June Rs.264
29th June Rs.264

Why should you invest in Emcure Pharmaceuticals Ltd. IPO?

Investing in Emcure Pharmaceuticals IPO presents a compelling opportunity due to several factors:

  1. Strong Market Position: Emcure ranks 13th in domestic sales among Indian pharmaceutical companies and holds leading positions in therapeutic areas like gynecology and HIV antivirals.
  2. Diverse Product Portfolio: The company’s extensive portfolio includes orals, injectables, and biotherapeutics, catering to both chronic and acute therapeutic areas.
  3. Global Presence: With a robust presence in over 70 countries, Emcure has established a significant market footprint in Europe and Canada, contributing to its overall revenue.
  4. Robust R&D Capabilities: Emcure's in-house R&D expertise has resulted in the development of complex molecules and novel drug delivery systems, providing a competitive edge.
  5. Manufacturing Excellence: The company’s vertically integrated manufacturing capabilities ensure cost-efficiency and quality control across its product range.

Emcure Pharmaceuticals IPO Noteworthy Highlights

  • IPO Size: The IPO is valued at ₹1,952.03 crore, comprising a fresh issue of 79 lakh shares aggregating to ₹800 crore and an offer-for-sale (OFS) of 1.14 crore shares.
  • Price Band: The price band is set at ₹960 to ₹1008 per share.
  • Lot Size: Investors can bid for a minimum of 14 shares, with an investment starting at ₹14,112 at the upper end of the price band.
  • Listing: The shares will be listed on both NSE and BSE on July 10, 2024.


Financial Snapshot - Emcure Pharmaceuticals Limited IPO

Check out the financial performance of Emcure Pharmaceuticals for recent years:

Financial Year Total Assets Total Revenues Net Profit
March 2022 Rs 6,063.47 crore Rs 5,918.86 crore Rs 702.56 crore
March 2023 Rs 6,672.53 crore Rs 6,031.72 crore Rs 561.85 crore
March 2024 Rs 7,806.16 crore Rs 6,715.24 crore Rs 527.58 crore

Emcure Pharmaceuticals Ltd. IPO - SWOT Analysis


  • Strong market position in India and international markets.
  • Diverse and comprehensive product portfolio.
  • Robust R&D capabilities and patent portfolio.
  • Vertically integrated manufacturing capabilities.


  • Regulatory compliance and quality control challenges.
  • Dependence on third-party suppliers for some products.
  • High working capital requirements.


  • Expansion in emerging markets.
  • Development of new and innovative products.
  • Strategic acquisitions and partnerships.


  • Regulatory changes and compliance issues.
  • Intense competition from established players.
  • Economic fluctuations and market dynamics.

How to apply for Emcure Pharmaceuticals Ltd. IPO?

You can apply for the Emcure Pharmaceuticals Ltd. IPO in these ways:

Link your personal bank A/C to a trusted UPI ID and map it with your TradeSmart account. Now, proceed further to book your IPO. On acceptance of the mandate, the bid amount will get blocked in your bank account Learn more.

Demat Account

1. If you are an Existing TradeSmart demat account holder and wish to apply for an Emcure Pharmaceuticals Ltd. click here.
2. If you don't have a TradeSmart Account? Sign up.

Looking to invest in an IPO?

Open Demat Account at lowest Brokerage

Emcure Pharmaceuticals Ltd. IPO FAQs

When will Emcure Pharmaceuticals IPO open and close?

The IPO will open on July 3, 2024, and close on July 5, 2024.

What is the price band for Emcure Pharmaceuticals IPO?

The price band is set at ₹960 to ₹1008 per share.

What is the lot size for Emcure Pharmaceuticals IPO?

The minimum lot size is 14 shares.

How much can retail investors invest in Emcure Pharmaceuticals IPO?

Retail investors can invest a minimum of ₹14,112 (at the upper end of the price band).

When will the shares be credited to my Demat account?

The shares will be credited on July 9, 2024.

When is the Emcure Pharmaceuticals IPO listing date?

The shares will be listed on July 10, 2024.

Who are the lead managers for the IPO?

The lead managers are Kotak Mahindra Capital Company Limited, Axis Capital Limited, J.P. Morgan India Private Limited, and Jefferies India Private Limited.

What are the objectives of the Emcure Pharmaceuticals IPO?

The net proceeds will be used to repay or prepay outstanding borrowings and for general corporate purposes.


Open Demat Account With TradeSmart

Lowest Brokerage Ever Trade @15 Per Order
Download TradeSmart App Now

Scan below QR Code
to download App

Open Demat Account